The Randox Acusera Maternal Screening control is the only commercially available control to cover all six analytes used during first and second trimester screening of Down’s Syndrome and Spina Bifida.
Assayed instrument specific target values and ranges are provided for AFP, β hCG, Inhibin A, PAPP-A, Total hCG and Unconjugated Estriol. The inclusion of Inhibin A and PAPP-A eliminates the need to purchase additional controls at extra expense.Maternal Screening Control Features:
- Lyophilised for enhanced stability
- 100% human serum
- Third party control
- Unconjugated oestriol present at clinically significant levels
- Reconstituted stability of 7 days at +2-8oC
AFP β hCG Inhibin A PAPP-A Total hCG Unconjugated Estriol